Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -2 of 2 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				Over 18				Pharmaceutical / Industry				TBC-PAN-003 NCT00088660

Last Modified: 10/10/2008 First Published: 8/24/2004


2.		Phase II Pilot Study of Vaccination Comprising Recombinant Vaccinia-CEA-MUC-1-TRICOM Vaccine, Recombinant Fowlpox-CEA-MUC-1-TRICOM Vaccine, and Sargramostim (GM-CSF) in Adults With Metastatic Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				NCI-04-C-0246 6536, NCI-6536, NCT00091000

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute